Cargando…
Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia
The Notch signaling pathway has been recognized as a key factor for the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL), because of the high incidence of activating mutations of Notch1. Notch inhibition could serve as a new treatment strategy for T-ALL; however, the attempts to perturb N...
Autores principales: | Koyama, D, Kikuchi, J, Hiraoka, N, Wada, T, Kurosawa, H, Chiba, S, Furukawa, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051216/ https://www.ncbi.nlm.nih.gov/pubmed/24301524 http://dx.doi.org/10.1038/leu.2013.366 |
Ejemplares similares
-
Alkylating agents induce histone H3K18 hyperacetylation and potentiate HDAC inhibitor-mediated global histone acetylation and cytotoxicity in mantle cell lymphoma
por: Hiraoka, N, et al.
Publicado: (2013) -
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia
por: Kamens, Jennifer L., et al.
Publicado: (2023) -
TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells
por: Riz, Irene, et al.
Publicado: (2010) -
Author Correction: Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia
por: Kamens, Jennifer L., et al.
Publicado: (2023) -
CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1- induced T cell acute lymphoblastic leukemia
por: Jena, Nilamani, et al.
Publicado: (2015)